홈 > 시장보고서 > 의료기기 > 수술관련기기

시장보고서

상품코드

1542978

세계의 근막절개술 시장(2024-2031년)

Global Fasciotomy Market - 2024-2031

발행일: 2024년 08월 | 리서치사:

DataM Intelligence | 페이지 정보: 영문 181 Pages | 배송안내 : 1-2일 (영업일 기준)

■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 근막절개술 시장 규모는 2023년 41억 5,000만 달러에 달하고, 2024-2031년 연평균 6.3%로 성장하여 2031년에는 66억 8,000만 달러에 달할 것으로 예상됩니다.

근막절개술은 조직과 근육 부위에 발생하는 혈액순환 장애를 치료하기 위해 근막을 절단하여 긴장과 압력을 완화하는 수술입니다. 근막절개술은 급성 구획증후군을 치료할 때 사지를 구할 수 있습니다. 또한 만성 구획 스트레스 증후군을 치료하는 데도 사용되기도 합니다. 이 수술의 성공률은 매우 높으며, 가장 흔한 문제는 실수로 주변 신경을 손상시키는 것입니다.

수술 전에 의사는 국소 마취 또는 전신 마취를 시행합니다. 외과 의사는 환부의 근육 구획을 절개하고 압박을 완화하고 근육과 신경으로의 혈류를 증가시키기 위해 제한성 근막(두꺼운 결합 조직)을 엽니다. 여러 근육이 침범된 경우 여러 개의 절개가 필요할 수도 있습니다.

시장 역학:

촉진요인

구획증후군 유병률 증가

세계 근막절개술 시장의 수요는 여러 요인에 의해 주도되고 있습니다. 구획증후군의 유병률 증가는 시장 성장을 촉진합니다.

또한, 치료 수요는 기술 발전으로 인해 더욱 촉진될 것입니다. 예를 들어, nih.gov에 따르면 급성 구획증후군의 발생률은 남성의 경우 10만 명당 7.3명, 여성의 경우 10만 명당 0.7명으로 추정되며, 대부분의 사례는 외상 후 발생합니다. 경골 축 골절은 급성 구획증후군의 가장 흔한 원인이며, 급성 구획증후군의 발병률은 1-10%입니다.

급성 구획증후군은 35세 미만의 남성에게 많이 나타나는데, 이는 상대적으로 구획 내 근육량이 많아 고에너지 외상을 입을 가능성이 높기 때문인 것으로 추정됩니다. 혈우병과 같은 출혈성 질환을 앓고 있는 환자는 급성 구획증후군의 위험이 높습니다. 급성 구획증후군의 사례는 급성 전구 외상 없이 소아 백혈병에서 보고된 바 있습니다.

억제요인

높은 시술 비용과 새로운 치료법 승인에 대한 엄격한 규제 요건 등이 시장의 걸림돌로 작용할 것으로 예상됩니다.

시장 부문 분석

세계 근막절개술 시장은 유형, 용도, 최종사용자 및 지역별로 세분화됩니다.

피부이식 근막절개기구(STSG)는 전 세계 근막절개술 시장 점유율의 약 58%를 차지합니다.

피부 이식 근막절개술(STSG) 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이 부문은 정부 규제 개선과 민간 제조업체의 연구 자금 증가가 이 시장을 견인할 것으로 예상됩니다.

예를 들어, 2021년 4월 미국 식품의약국(FDA)은 Chemence Medical의 재설계된 Exofin fusion 피부 봉합 시스템에 510(k) 승인을 부여했습니다. 옥틸시아노아크릴레이트 국소 접착제를 제공하여 절개 부위를 덮고 밀봉하는 동시에 감염으로부터 보호하기 위한 즉각적인 미생물 장벽을 형성합니다.

지역별 시장 분석

북미가 근막절개술 세계 시장 점유율의 약 42%를 차지

북미는 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이 지역에서는 구획증후군 발병률 증가, 기술 발전, 사람들의 인식 증가가 시장을 주도하고 있습니다.

예를 들어, clevelandclinic.org에 따르면 전문가들은 미국에서 매년 10만 명 중 10명 미만이 급성 구획증후군을 경험하는 것으로 추정하고 있습니다. 그러나 특정 유형의 골절(골절)을 겪은 사람들에게는 더 흔합니다. 예를 들어, 연구에 따르면 경골 골절 환자의 약 10%가 구획증후군이 발생하는 것으로 추정됩니다.

예를 들어, 2020년 2월 바이오프린팅 기업 T&R Biofab은 Johnson & Johnson의 의료기기 회사인 Ethicon Llc., Inc. 이 제휴는 상처 치료 및 재건 수술 등에 사용되는 3D 바이오프린팅 연부조직 스캐폴드 개발을 목표로 하고 있습니다.

Fasciotomy is a surgical procedure where the fascia is cut to relieve tension or pressure to treat the resulting loss of circulation to an area of tissue or muscle. Fasciotomy is a limb-saving procedure when used to treat acute compartment syndrome. It is also sometimes used to treat chronic compartment stress syndrome. The procedure has a very high rate of success, with the most common problem being accidental damage to a nearby nerve.

Before the procedure, doctors administer regional or general anesthesia. The surgeon makes an incision above the affected muscle compartment, opening the restrictive fascia-thick sheets of connective tissue-to relieve pressure and increase blood flow to muscles and nerves. More than one incision may be required if multiple muscles are affected.

Market Dynamics: Drivers

Increasing prevalence of compartment syndrome

The demand for the global fasciotomy market is driven by multiple factors. The rising prevalence of compartment syndrome propels the market growth.

Furthermore, the demand for treatment will be fueled by technological advancements. For instance, according to nih.gov, The incidence of acute compartment syndrome is estimated to be 7.3 per 100,000 in males and 0.7 per 100,000 in females, with the majority of cases occurring after trauma. Tibial shaft fracture is the most common cause of acute compartment syndrome and is associated with a 1 to 10 percent incidence of acute compartment syndrome.

Acute compartment syndrome occurs more commonly in males younger than 35, which may be due to a larger relative intracompartmental muscle mass and increased likelihood of being involved in high-energy trauma. Patients with bleeding diathesis, such as hemophilia, are at greater risk for acute compartment syndrome. Cases of acute compartment syndrome have been reported without acute precipitating trauma in pediatric leukemia.

Restraints

Factors such as high costs associated with the procedure and stringent regulatory requirements for the approval of new treatments are expected to hamper the market.

Market Segment Analysis

The global fasciotomy market is segmented based on type, application, end-user, and region.

The segment skin graft fasciotomy instrument (STSG) accounted for approximately 58% of the global fasciotomy market share

The skin graft fasciotomy instrument (STSG) segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and rising funds for private manufacturers for research would drive this market.

For instance, in April 2021, the US Food and Drug Administration (FDA) granted 510(k) approval to Chemence Medical's redesigned Exofin fusion skin closure system. Exofin fusion offers a self-adhering, flexible mesh strip and a rapidly curing 2-octyl cyanoacrylate topical adhesive, which covers and seals incisions while also creating an immediate microbial barrier to protect against infections.

Market Geographical Analysis

North America accounted for approximately 42% of the global fasciotomy market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of compartment syndrome, technological advancements, and growing awareness among people, in this region, help to propel the market.

For instance, according to clevelandclinic.org, experts estimate that fewer than 10 in every 100,000 people in the U.S. experience acute compartment syndrome each year. However, it's much more common in people who have some types of bone fractures (broken bones). For example, studies estimate that around 10% of people who break their tibia develop compartment syndrome.

For instance, in February 2020, Bioprinting company T&R Biofab announced a new collaboration agreement with Ethicon Llc., Inc., a Johnson & Johnson Medical Device Company. The partnership aims to develop a 3D bioprinted soft tissue scaffold for wound treatments, reconstructive surgery, and more.

Market Segmentation

By Instrument

Skin Graft Fasciotomy Instrument (STSG)
Negative Pressure Wound Treatment Fasciotomy Instrument (NPWT)
Vascular Ring Technique Fasciotomy Instrument
Continuous External Tissue Expansion Fasciotomy Instrument (CETE)
Others

By Application

Plantar Fasciitis
Acute Compartment Syndrome
Chronic Compartment Syndrome
Others

By End-User

Hospitals
Specialty Clinics
Ambulatory and Surgery Centers
Others

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Market Competitive Landscape

The major global players in the global fasciotomy market include Zipline Medical Inc., Stryker Corporation, DermaClose, Terumo Corporation, Merit Medical Systems, Ethicon Llc., Cardinal Health, 3M, Biopro Inc., and Southmedic Inc. among others.

Key Developments

In June 2022, Advanced Medical Solutions, a specialist in tissue-healing technologies, received FDA 510(k) approval for LiquiBand XL, a new device that can close longer wounds. The device consists of a surgical mesh which is used to close the wound and LiquiBand glue which is used to strengthen the closure and prevent infection.
In May 2024, SouthMedic, a leading manufacturer of surgical blades, scalpels, and innovative medical devices, announced its partnership with Nano Surgical to become the exclusive master distributor of Lumohs MD no. 3 Lighted Scalpel Handles in Canada.

Why Purchase the Report?

To visualize the global fasciotomy market segmentation based on type, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global fasciotomy market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.

The global fasciotomy market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Compartment Syndrome
  - 4.1.1.2. Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Procedure
  - 4.1.2.2. Stringent Regulatory Requirements
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Skin Graft Fasciotomy Instrument*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Negative Pressure Wound Treatment Fasciotomy Instrument
6.4. Vascular Ring Technique Fasciotomy Instrument
6.5. Continuous External Tissue Expansion Fasciotomy Instrument
6.6. Vistide
6.7. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Plantar Fascitis*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Acute Compartment Syndrome
7.4. Chronic Compartment Syndrome
7.5. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory and Surgery Centers
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Zipline Medical Inc. *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Stryker Corporation
11.3. DermaClose
11.4. Terumo Corporation
11.5. Merit Medical Systems
11.6. Ethicon Llc.
11.7. Cardinal Health
11.8. 3M
11.9. Biopro Inc.
11.10. Southmedic Inc. (*LIST NOT EXHAUSTIVE)

12. Appendix

12.1. About Us and Services
12.2. Contact Us

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF & Excel (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,350

￦ 6,294,000

PDF & Excel (Multiple User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,850

￦ 7,017,000

PDF & Excel (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,850

￦ 11,358,000

※ 부가세 별도

세계의 근막절개술 시장(2024-2031년)

Global Fasciotomy Market - 2024-2031

시장 역학:

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

제5장 산업 분석

제6장 유형별

제7장 용도별

제8장 최종사용자별

제9장 지역별

제10장 경쟁 상황

제11장 기업 개요

제12장 부록